Trials / Conditions / EBV-associated Malignancies
EBV-associated Malignancies
3 registered clinical trials studyying EBV-associated Malignancies.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Safety and Effectiveness of EBV-specific Cytotoxic T Cells for the Treatment for EBV Lymphomas or Other EBV-as NCT03988582 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partial NCT01498484 | Atara Biotherapeutics | Phase 2 |
| Completed | Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Maligna NCT00002663 | Atara Biotherapeutics | Phase 1 / Phase 2 |